SNYR Stock Forecast & Price Target

Synergy CHC Corp reported net revenues of $8.0 million, reflecting a 12% increase from the previous year, indicating a positive growth trajectory despite being below estimates. The company experienced a favorable shift toward higher margin supplement revenue, achieving a gross margin of 67.2% in the third quarter of 2024. Furthermore, Synergy CHC's significant expansion of the FOCUSfactor brand, from 3 SKUs at acquisition to over 34 SKUs, exemplifies its commitment to product development and positions the company well for future sales and profitability enhancement.

Synergy CHC Corp experienced a disappointing Adjusted EBITDA of $1.3 million, which was unchanged from the previous year and fell short of analyst estimates, partly due to tight cash flow ahead of a recent equity raise. The company's share price has demonstrated significant weakness and volatility over the past year, reflecting growing concerns about consumer spending amid deteriorating economic conditions. Financial estimates for operating expenses have been revised downward, indicating cautious outlooks for profitability while uncertainty looms over revenues and performance metrics.